1. Cardiac metastatic melanoma
- Author
-
Jay Ramchand, Matias Yudi, Stephen Sylivris, and Geoffrey R. Wong
- Subjects
medicine.medical_specialty ,Ipilimumab ,Article ,030218 nuclear medicine & medical imaging ,Heart Neoplasms ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Melanoma ,Early Detection of Cancer ,Trametinib ,Past medical history ,medicine.diagnostic_test ,business.industry ,Dabrafenib ,General Medicine ,Middle Aged ,medicine.disease ,Metformin ,Treatment Outcome ,medicine.anatomical_structure ,Ventricle ,Positron emission tomography ,Positron-Emission Tomography ,030220 oncology & carcinogenesis ,Female ,Radiology ,business ,medicine.drug - Abstract
We describe the case of a 55-year-old woman presenting with a recent onset of mild cough and no other specific cardiovascular symptoms, and with a normal examination. Salient past medical history included BRAF-positive melanoma resected from the small bowel with abdominal, left inguinal and pulmonary metastases, 2 years prior. Following immunotherapy with combined dabrafenib and trametinib for 6 months and subsequently, ipilimumab, complete remission was achieved. The only other significant history was of type 2 diabetes mellitus with metformin therapy. Plain radiographs of the chest were unremarkable, and a subsequent fluorodeoxyglucose positron emission tomography (FDG PET) demonstrated focal uptake in the anterior left ventricle (figure 1). Transoesophageal echocardiography (TOE) demonstrated a large, voluminous intracavitary left ventricular mass (45×25 mm) attached to the mid anterior wall without evidence of obstruction (figure 2, video 1). Cardiac MRI confirmed a mass with increased signal intensity on T1-weighted imaging suggestive of metastatic melanoma in …
- Published
- 2016
- Full Text
- View/download PDF